aztreonam has been researched along with chloramphenicol in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (5.26) | 18.7374 |
1990's | 7 (18.42) | 18.2507 |
2000's | 17 (44.74) | 29.6817 |
2010's | 12 (31.58) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, ML; Duffield, J; Hu, C; Hwang, SB; Ichikawa, Y; Liang, CH; Marby, KA; Rabuka, D; Romero, A; Sears, P; Sgarbi, PW; Shue, YK; Sucheck, SJ; Yao, S | 1 |
Alba, L; Chen, Y; Garber, E; Saiman, L; Tabibi, S; Zhou, J | 1 |
Ayala, JA; Casellas, JM; Di Conza, J; Ghiglione, B; Gutkind, G; Power, P; Radice, M; Rodríguez, MM | 1 |
Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
Borrell, N; Maciá, MD; Moya, B; Oliver, A; Pérez, JL; Plasencia, V | 1 |
Chen, YT; Lauderdale, TL; Liao, TL; Shiau, YR; Shu, HY; Su, IJ; Tsai, SF; Wu, KM; Yan, JJ | 1 |
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Attree, I; Elsen, S; Jeannot, K; Köhler, T; Plésiat, P; van Delden, C | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Hanaki, H; Maseda, H; Nakae, T; Sugimura, M | 1 |
Christiansen, LE; Ciofu, O; Høiby, N; Kirkby, N; Mandsberg, LF; Poulsen, HE | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Akiba, K; Ando, T; Hori, H; Nakae, T; Yoneyama, H | 1 |
Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hibi, S; Imashuku, S; Nakajima, F; Takaya, K; Todo, S | 1 |
Farid, Z; Girgis, NI; Kilpatrick, ME; Podgore, JK; Sultan, Y | 1 |
Ariffin, WA; Choo, KE; Ong, KH; Sivakumaran, S | 1 |
Bishay, E; Farid, Z; Girgis, NI; Kamal, M; Kilpatrick, ME | 1 |
Ford, M; Gould, FK; Venning, MC | 1 |
Ortega, L; Santos, JI; Tanaka-Kido, J | 1 |
Rouan, MC | 1 |
Alford, RH; Brown, TH | 1 |
Carrillo, C; DuPont, HL; Echevarría, J; Gotuzzo, E; Grados, P; Maguiña, C; Sánchez, J | 1 |
Izumi, S; Maseda, H; Nakae, T; Yamabayashi Ta, TA; Yoneyama, H | 1 |
Burioni, R; Canducci, F; Carletti, S; Cavallero, A; Clementi, M; Mancini, N; Perotti, M | 1 |
Amoureux, L; Bador, J; Drabowicz, A; Duez, JM; Llanes, C; Neuwirth, C; Siebor, E | 1 |
Akiba, K; Ando, T; Isogai, E; Maseda, H; Matsumoto, Y; Nakae, T; Sato, K; Ushioda, K; Yoneyama, H | 1 |
3 review(s) available for aztreonam and chloramphenicol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Recombinant human granulocyte-colony stimulating factor (rhG-CSF) treatment for spleen abscess and periostitis in a patient with chronic granulomatous disease].
Topics: Abscess; Aztreonam; Ceftizoxime; Child; Chloramphenicol; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Granulomatous Disease, Chronic; Humans; Infusions, Intravenous; Male; Periostitis; Recombinant Proteins; Splenic Diseases | 1992 |
Antibiotic monitoring in body fluids.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Biological Assay; Body Fluids; Cephalosporins; Chloramphenicol; Chromatography, Gas; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Humans; Immunoassay; Monitoring, Physiologic; Penicillins; Rifampin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Thiamphenicol; Vancomycin | 1985 |
4 trial(s) available for aztreonam and chloramphenicol
Article | Year |
---|---|
Aztreonam compared to chloramphenicol in the treatment of enteric fevers.
Topics: Administration, Oral; Adolescent; Adult; Aztreonam; Child; Chloramphenicol; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Typhoid Fever | 1992 |
Aztreonam failure in typhoid fever.
Topics: Aztreonam; Child; Chloramphenicol; Drug Evaluation; Drug Resistance, Microbial; Humans; Prospective Studies; Salmonella typhi; Typhoid Fever | 1991 |
Comparative efficacies of aztreonam and chloramphenicol in children with typhoid fever.
Topics: Adolescent; Alkaline Phosphatase; Aztreonam; Child; Child, Preschool; Chloramphenicol; Clinical Trials as Topic; Humans; Random Allocation; Typhoid Fever | 1990 |
Randomized comparison of aztreonam and chloramphenicol in treatment of typhoid fever.
Topics: Adolescent; Adult; Aztreonam; Chloramphenicol; Double-Blind Method; Feces; Female; Humans; Male; Paratyphoid Fever; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever | 1994 |
31 other study(ies) available for aztreonam and chloramphenicol
Article | Year |
---|---|
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Structure-Activity Relationship | 2005 |
Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests | 2007 |
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalysis; Citrobacter freundii; Conjugation, Genetic; DNA, Bacterial; DNA, Recombinant; Enterobacteriaceae; Genes, Bacterial; Humans; Hydrolysis; Isoelectric Focusing; Kinetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Protein Sorting Signals; Sequence Analysis, DNA | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2007 |
Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Genomics; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Ciprofloxacin; DNA Primers; DNA-Binding Proteins; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Male; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Molecular Sequence Data; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Transcription Factors; Virulence | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Outer Membrane Proteins; Down-Regulation; Humans; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing | 2008 |
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
Topics: Cystic Fibrosis; DNA Repair; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Neutrophil Activation; Oxidation-Reduction; Oxidative Stress; Pseudomonas aeruginosa | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Tat pathway-mediated translocation of the sec pathway substrate protein MexA, an inner membrane component of the MexAB-OprM xenobiotic extrusion pump in Pseudomonas aeruginosa.
Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; Base Sequence; DNA Primers; DNA, Bacterial; Genes, Bacterial; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Plasmids; Pseudomonas aeruginosa; Recombinant Fusion Proteins; Transferases (Other Substituted Phosphate Groups); Xenobiotics | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Successful aztreonam treatment of acute typhoid fever after chloramphenicol failure.
Topics: Adult; Aztreonam; Chloramphenicol; Female; Humans; Male; Salmonella typhi; Typhoid Fever | 1990 |
Successful treatment with chloramphenicol of Pseudomonas mesophilica peritonitis not responding to aztreonam and gentamicin.
Topics: Aged; Aztreonam; Chloramphenicol; Gentamicins; Humans; Male; Peritonitis; Pseudomonas Infections | 1990 |
Antagonism by chloramphenicol of broad-spectrum beta-lactam antibiotics against Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chloramphenicol; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Thienamycins; Time Factors | 1984 |
Secondary-site mutation restores the transport defect caused by the transmembrane domain mutation of the xenobiotic transporter MexB in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Outer Membrane Proteins; Biological Transport; Carrier Proteins; Chloramphenicol; Drug Resistance, Bacterial; Kinetics; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Mutation; Ofloxacin; Protein Structure, Tertiary; Pseudomonas aeruginosa; Transformation, Bacterial; Xenobiotics | 2002 |
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction.
Topics: Anti-Bacterial Agents; Aztreonam; Bacillus; Bacterial Proteins; Chloramphenicol; Colony Count, Microbial; Culture Media; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Humans; Methyltransferases; Polymerase Chain Reaction; Probiotics | 2006 |
First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM.
Topics: Achromobacter denitrificans; Aztreonam; Bacterial Outer Membrane Proteins; Cephalosporins; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Nalidixic Acid | 2011 |
Development of a novel antimicrobial screening system targeting the pyoverdine-mediated iron acquisition system and xenobiotic efflux pumps.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Outer Membrane Proteins; Biological Transport; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gentamicins; Iron; Iron Chelating Agents; Membrane Transport Proteins; Microbial Sensitivity Tests; Oligopeptides; Pseudomonas aeruginosa | 2015 |